Gerd Horneff

Arnold Janssen Str. 29
Sankt Augustin, NW 53757, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 203 publications

Canakinumab for systemic-onset juvenile idiopathic arthritis/Still's disease-effectiveness and safety data from the BiKeR registry.

Canakinumab for systemic-onset juvenile idiopathic arthritis/Still's disease-effectiveness and safety data from the BiKeR registry.

Journal: EULAR rheumatology open

Published: August 01, 2026

What is the treatment pattern of juvenile systemic sclerosis? Results from an international cohort.

What is the treatment pattern of juvenile systemic sclerosis? Results from an international cohort.

Journal: Journal of scleroderma and related disorders

Published: April 15, 2026

Serological biomarkers of JIA-associated uveitis: ANA titers, ANA AC-30 staining pattern and prefoldin 5 antibodies.

Serological biomarkers of JIA-associated uveitis: ANA titers, ANA AC-30 staining pattern and prefoldin 5 antibodies.

Journal: Arthritis research & therapy

Published: January 13, 2026

Effectiveness of Canakinumab for First-Line Steroid-Free Treatment in Systemic-Onset Juvenile Idiopathic Arthritis and Juvenile Still Disease.

Effectiveness of Canakinumab for First-Line Steroid-Free Treatment in Systemic-Onset Juvenile Idiopathic Arthritis and Juvenile Still Disease.

Journal: ACR open rheumatology

Published: November 24, 2025

Improving care for children with juvenile idiopathic arthritis: the role of IL-6 inhibitors in a patient-centered approach.

Improving care for children with juvenile idiopathic arthritis: the role of IL-6 inhibitors in a patient-centered approach.

Journal: Expert opinion on biological therapy

Published: October 18, 2025

Emotional well-being at diagnosis may indicate future mental health risk in patients with juvenile idiopathic arthritis: data from the German inception cohort ICON.

Emotional well-being at diagnosis may indicate future mental health risk in patients with juvenile idiopathic arthritis: data from the German inception cohort ICON.

Journal: RMD open

Published: September 10, 2025

PRO-KIND consensus protocol for classification, monitoring, and therapy in pediatric rheumatology: persistent oligoarticular juvenile idiopathic arthritis.

PRO-KIND consensus protocol for classification, monitoring, and therapy in pediatric rheumatology: persistent oligoarticular juvenile idiopathic arthritis.

Journal: Frontiers in pediatrics

Published: September 01, 2025

Juvenile idiopathic arthritis-persistent oligoarticular subtype : Consensus-based treatment recommendations as part of the ProKind Rheuma Initiative

Juvenile idiopathic arthritis-persistent oligoarticular subtype : Consensus-based treatment recommendations as part of the ProKind Rheuma Initiative

Journal: Zeitschrift fur Rheumatologie

Published: August 02, 2025

Infant-onset juvenile idiopathic arthritis: a multicentre retrospective study.

Infant-onset juvenile idiopathic arthritis: a multicentre retrospective study.

Journal: Rheumatology (Oxford, England)

Published: July 08, 2025

Inflammatory CD4+ T cells can waive NRF2-dependent SLC7A11-mediated cystine uptake by using ASCT1.

Inflammatory CD4+ T cells can waive NRF2-dependent SLC7A11-mediated cystine uptake by using ASCT1.

Journal: iScience

Published: July 07, 2025

Use of IL-1 inhibitors in the treatment of familial Mediterranean fever in pediatric rheumatology

Use of IL-1 inhibitors in the treatment of familial Mediterranean fever in pediatric rheumatology

Journal: Zeitschrift fur Rheumatologie

Published: July 05, 2025

Long-term Effectiveness and Safety of Canakinumab in Patients with TRAPS: Analysis of the RELIANCE Non-Interventional Study.

Long-term Effectiveness and Safety of Canakinumab in Patients with TRAPS: Analysis of the RELIANCE Non-Interventional Study.

Journal: Rheumatology and therapy

Published: April 10, 2025

Showing 1-12 of 203

Last Updated: 09/26/2026